CaspACE™ FITC-VAD-FMK In Situ Marker Protocol
Literature # 9PIG746
CaspACE™ FITC-VAD-FMK In Situ Marker is a fluoroisothiocyanate (FITC) conjugate of the cell permeable caspase inhibitor VAD-FMK. This structure allows delivery of the inhibitor into the cell where it binds to activated caspase, serving as an in situ marker for apoptosis. The bound marker is localized by fluorescence detection.
Printed in USA. Revised 9/16